Elastomeric infusion pumps market seen reaching $1.8 billion by 2030

The elastomeric infusion pumps market is projected to grow from $1.16 billion in 2025 to $1.8 billion by 2030 as home-based care, outpatient treatment and pain management use cases expand. North America held the largest share in 2025, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - Elastomeric infusion pumps support treatment outside traditional hospital settings, including home care, outpatient care and ambulatory surgery. - The market’s growth reflects broader shifts toward portable, disposable and simpler drug-delivery systems. - Rising demand matters for hospitals, home-care providers and patients who need ongoing infusion therapy with more mobility and convenience.

What happened: - The Business Research Company said the elastomeric infusion pumps market is set to rise from $1.16 billion in 2025 to $1.27 billion in 2026. - The market is forecast to reach $1.8 billion by 2030. - The report projects a 9.3% CAGR in 2026 and a 9.2% CAGR from 2026 to 2030. - The company released a free sample report and a full market report online: Download a free sample and View the full report.

The details: - Elastomeric infusion pumps are medical devices that deliver medications or fluids over a preset period. - The pumps are used for antibiotics, pain management and chemotherapy. - The market’s recent growth is tied to chronic disease management, outpatient hospital services, improved accessibility of elastomeric pumps and higher demand for pain management. - The expected expansion through 2030 is linked to homecare treatment models, chemotherapy outside hospitals, ambulatory surgical centers, patient mobility and higher spending on infusion therapies. - Reported market trends include wider adoption of home-based infusion therapies, more portable and disposable pumps, expanded pain management use, a shift toward outpatient and ambulatory infusions and demand for simplified drug delivery systems. - A December 2024 NHS report showed 552,592 emergency admissions in the UK that month, up 1.2% from December 2023. - The report said higher hospital admissions can increase demand because elastomeric pumps help support early discharge and continued treatment at home. - The Centers for Medicare & Medicaid Services reported in December 2024 that U.S. healthcare spending rose 7.5% in 2023 to $4.9 trillion, or about $14,570 per person. - The report said higher healthcare spending supports adoption of advanced infusion devices, specialty therapies and staff training.

Between the lines: - The market outlook suggests elastomeric pumps are moving from a niche device category toward a broader role in care delivery. - Homecare and outpatient settings appear to be the main demand engine, which aligns with pressure to reduce hospital occupancy and improve patient comfort. - North America led the market in 2025, but the fastest growth is expected in Asia-Pacific, signaling where future volume may shift.

What's next: - The market analysis covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The Business Research Company said its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards, market hotspots infographics, and updated trend analysis. - The company also listed contact information for expert inquiries and follow-up on the report.

The bottom line: - Elastomeric infusion pumps are on a steady growth path as healthcare systems push more infusion therapy into home and outpatient settings.